# Glass House Brands Inc.: financial statements, quarterly

GLAS · NYSE · CIK 1848731 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/glas.md) · [Financials](/companies/glas/financials.md) · [Filings](/companies/glas/filings.md) · [Insiders](/companies/glas/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/glas/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [4.5](/filings/0001104659-22-041796.md) | [51.1](/filings/0001104659-24-042091.md) | [11.1](/filings/0001104659-24-042091.md) | [29.5](/filings/0001848731-25-000007.md) | [33.9](/filings/0001848731-26-000015.md) | [19.9](/filings/0001848731-26-000015.md) |
| Current assets | $m | not reported | [18.5](/filings/0001104659-22-041796.md) | [68.6](/filings/0001104659-24-042091.md) | [38.9](/filings/0001104659-24-042091.md) | [49.2](/filings/0001848731-25-000007.md) | [66.1](/filings/0001848731-26-000015.md) | [67.7](/filings/0001848731-26-000015.md) |
| Total assets | $m | not reported | [69.5](/filings/0001104659-22-041796.md) | [288](/filings/0001104659-24-042091.md) | [351](/filings/0001104659-24-042091.md) | [304](/filings/0001848731-25-000007.md) | [311](/filings/0001848731-26-000015.md) | [319](/filings/0001848731-26-000015.md) |
| Current liabilities | $m | not reported | [19.6](/filings/0001104659-22-041796.md) | [55.2](/filings/0001104659-24-042091.md) | [54.0](/filings/0001104659-24-042091.md) | [87.4](/filings/0001848731-25-000007.md) | [66.5](/filings/0001848731-26-000015.md) | [38.0](/filings/0001848731-26-000015.md) |
| Total liabilities | $m | not reported | [43.3](/filings/0001104659-22-041796.md) | [106](/filings/0001104659-24-042091.md) | [129](/filings/0001104659-24-042091.md) | [159](/filings/0001848731-25-000007.md) | [146](/filings/0001848731-26-000015.md) | [144](/filings/0001848731-26-000015.md) |
| Long-term debt | $m | not reported | [15.4](/filings/0001104659-22-041796.md) | [44.8](/filings/0001104659-24-042091.md) | [62.6](/filings/0001104659-24-042091.md) | [56.5](/filings/0001848731-25-000007.md) | [50.6](/filings/0001848731-26-000015.md) | [68.6](/filings/0001848731-26-000015.md) |
| Current portion of debt | $m | not reported | [0.6](/filings/0001104659-22-041796.md) | [0.0](/filings/0001104659-24-042091.md) | [0.0](/filings/0001104659-24-042091.md) | [7.6](/filings/0001848731-25-000007.md) | [7.6](/filings/0001848731-26-000015.md) | [0.0](/filings/0001848731-26-000015.md) |
| Shareholders' equity | $m | [38.6](/filings/0001104659-22-041796.md) | [26.3](/filings/0001104659-24-042091.md) | [182](/filings/0001104659-24-042091.md) | [169](/filings/0001104659-24-042091.md) | [89.8](/filings/0001848731-25-000007.md) | [116](/filings/0001848731-26-000015.md) | [73.9](/filings/0001848731-26-000015.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.